
The Algerian Group 'Saïdal' Signs Agreement with German 'Boehringer Ingelheim' to Localize Innovative Medicines
The Algerian pharmaceutical industrial group 'Saïdal' signed a cooperation agreement today, Monday, with the leading German company in the research and development of biopharmaceuticals 'Boehringer Ingelheim', aimed at localizing the manufacturing and production of an innovative treatment for pulmonary fibrosis in Algeria. The signing ceremony was overseen by the Minister of Pharmaceutical Industry, Wassim Gouidri, and the Ambassador of the Federal Republic of Germany to Algeria, George Felsheim, at the production unit of the Saïdal group in El Harrach, Algiers.













